Study to assess effect of device and formulation on Pharmacokinetics (PK) of AZD1402

Trial Identifier: D2912C00001
Sponsor: AstraZeneca
NCTID:: NCT03921268
Start Date: March 2019
Primary Completion Date: June 2019
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
English UK translation

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ